Pro-Kremlin media are drumming up support for the Sputnik V vaccine by creating the perception that the European Medicines Agency (EMA) has initiated negotiations with the developer of the Russian vaccine, the Gamaleya Centre.
Coronavirus
OP-ED
EUvsDisinfo: Subtle art of information manipulation
A picture taken on Dec. 4, 2020, shows the production of Russia's Gam-COVID-Vac vaccine against the coronavirus disease (Covid-19) registered under trade name Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in coordination with the Russian Defence Ministry, at the facility of Russia's biotech company BIOCAD in Strelna outside Saint Petersburg.
